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Abstract To investigate mechanisms of interferon (IFN)
resistance, we have established an IFN-resistant Daudi subline
(Daudires), which is 1U104 times more resistant to IFN-K than
parental cells. Among the IFN-inducible genes examined, only
ICE mRNA expression was deficient in Daudires cells. We then
analyzed the regulatory mechanisms of ICE transcription, and
found that IFN-induced activation of the ICE promoter was
dependent on the binding of IRFs to its initiator (Inr) element.
Inr binding of IRFs was markedly diminished in Daudires cells,
and forced expression of IRF-1 was able to activate the ICE
promoter to the level of parental cells. These results suggest that
IRFs and their target genes, as represented by ICE in this study,
are involved in IFN resistance.
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1. Introduction
Interferon is now widely used as a therapeutic reagent for
cancer and virus infection, and its resistance is an important
clinical problem [1]. A signi¢cant number of patients do not
respond to IFN even at the time of initial therapy, and many
patients become resistant after long-term treatment [1].
Although IFN resistance can be partially explained by the
development of anti-IFN neutralizing antibody in the latter
case, its underlying mechanisms are largely unknown. Insights
into the molecular mechanisms of IFN resistance are neces-
sary for better clinical application.
Recent studies have revealed that the mechanisms of IFN
action are diverse. Binding of IFN-K/L to type I receptors
activates JAK1 and TYK2 kinases that in turn phosphorylate
cytoplasmic STAT (signal transducers and activators of tran-
scription) proteins including STAT1K, STAT1L, and STAT2
[2]. The phosphorylated STAT proteins are translocated into
the nucleus and form a complex called ISGF3 (interferon-
stimulated gene factor 3) with p48 (ISGF3Q). ISGF3 complex
binds to the IFN-stimulated response element (ISRE) in the
promoter of a group of IFN-stimulated genes and induces
their transcription. On the other hand, IFN-Q activates
JAK1 and JAK2 kinases through type II receptor and induces
phosphorylation of STAT1K. Upon phosphorylation, STAT1K
dimerizes and binds to the Q-IFN-activated site (GAS) or
GAS-like elements in the promoter of various target genes
to activate their transcription. Via these signaling pathways,
IFNs can induce expression of proteins with distinct func-
tions, such as (2P-5P) oligoadenylate synthetase (2P-5P-AS)
[3], 2P-5P-AS-dependent ribonuclease L (RNase L) [4], and
double-stranded RNA-dependent protein kinase (PKR) [5],
to exert many biological activities.
To investigate the mechanisms of IFN resistance, we have
recently established a novel IFN-resistant cell line Daudires
from human B-lymphoblastoid cell line Daudi. In contrast
to the parental Daudi (hereinafter referred to as Daudisen
for discrimination), the growth of Daudires cells is not inhib-
ited by IFN. Using this cell line, we analyzed the expression of
various genes involved in the signal transduction and function
of IFN, and found that induction of interleukin-1L-converting
enzyme (ICE) mRNA was de¢cient in Daudires cells. We then
studied the molecular mechanisms of defective ICE expression
in this cell line, and discussed the implications for IFN resist-
ance.
2. Materials and methods
2.1. Establishment of an IFN-resistant Daudi cell line (Daudires) and
cell culture
An IFN-resistant subline was established by long-term exposure of
IFN-K (Sumitomo Pharmaceutical Co., Osaka, Japan) to Daudisen
cells. Culture was started at 3U105 cells/ml in growth medium con-
taining 100 IU/ml of IFN-K, and the medium was changed every 2 or
3 days to maintain viable cells at the concentration of 3U105 cells/ml
in the presence of IFN. Growth of surviving cells was observed after 6
to 7 weeks, and the cells were subcloned in methylcellulose containing
IFN-K to obtain a single cell clone. Regrowth assay revealed that the
EC50 of Daudisen and Daudires was 10 IU/ml and 1U105 IU/ml,
respectively, indicating that the Daudires cell line is 1U104 times
more resistant to IFN-K than the parental Daudisen cell line.
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2.2. Reverse transcription-polymerase chain reaction (RT-PCR)
analysis
Semiquantitative RT-PCR was carried out as previously described
[6]. The ampli¢cation cycles numbered 25 except for ICE (28 cycles).
Information of the primer sequences is available on request.
2.3. Immunoblotting
Immunoblotting was performed with anti-STAT1 (E-23) and anti-
STAT2 (C-20) antibodies (Santa Cruz Biotechnology, Santa Cruz,
CA, USA) according to the standard method.
2.4. Gel-retardation assays
Nuclear extracts (5 Wg) were incubated with approximately 0.5 ng
(10 000 cpm) of (32P)-labeled double-stranded oligonucleotides in the
presence of 1 Wg each of sonicated salmon sperm DNA and poly(dI-
dC). The protein-DNA complexes were resolved on a 4% polyacryl-
amide gel in 0.25UTris-borate-EDTA bu¡er.
Probes used in this study are as follows (sense strands are shown;
consensus sequence is underlined, and mutated sites are shown in
boldface): IRF element, 5P-AGCATACTTTCAGTTTCAGTCACA-
CA-3P ; mutant IRF element, 5P-AGCATACCCTCAGCCTCAGT-
CACACA-3P (Fig. 1) [7]. The following antibodies (1 Wg each) were
included in the reaction mixture for antibody perturbation experi-
ments: anti-IRF-1 (C-20), anti-IRF-2 (C-19), anti-STAT1 (E-23),
anti-STAT2 (C-20), anti-ICSBP (C-19), anti-ISGF3Q (C-20) (all pur-
chased from Santa Cruz Biotechnology).
2.5. Reporter plasmids
A 5P-untranslated region of the human ICE promoter (nucleotide
positions 3182 to +42 relative to the transcription start site) was
subcloned into pCAT-basic vector (Promega, Madison, WI, USA),
which was then used as a reporter plasmid pCAT-5P-ICE-WT. Mu-
tated reporter plasmid, pCAT-5P-ICE-MT, was prepared by PCR-
based site-directed mutagenesis [8] using 5P-AGCATACCCT-
CAGCCTCAGTCACACA-3P as a mutagenesis primer (mutated sites
are in boldface) (Fig. 1).
2.6. Expression plasmids
IRF-1 and IRF-2 expression plasmids were constructed by ligating
full-length cDNAs into pCR3.1 vector (Invitrogen).
2.7. Transient transfection and CAT assay
Reporter plasmids were linearized and transfected into cells by a
Gene Pulser (Bio-Rad Laboratories) [9]. The cells were split equally
into two £asks and cultured for 24 h after adding 250 IU/ml of IFN-K
to one £ask. For cotransfection assays, cells were transfected with 30
Wg of reporter plasmid, 4 Wg of L-galactosidase expression plasmid
(pSV-L-gal, Promega), and 8 Wg of IRF-1 expression plasmid. CAT
and L-galactosidase activities were determined after 24 h.
3. Results
3.1. Expression of IFN-inducible molecules in Daudisen and
Daudires cells
In an attempt to understand the molecular basis of the IFN
resistance of Daudires cells, we screened for expression of the
molecules involved in signal transduction of IFN (IFN recep-
tor, STAT1 and STAT2) and their functions (2P-5P-AS, RNase
L, PKR and ICE) in IFN-treated Daudisen and Daudires cells
by semiquantitative RT-PCR. As shown in Fig. 2a, IFN-K
was able to induce or enhance the expression of a number
of IFN-inducible genes in Daudires cells as well as in Daudisen
cells. Immunoblotting also revealed that there was no signi¢-
cant di¡erence in the amounts of STAT1 and STAT2 proteins
between the two cell lines (Fig. 2b). Among the IFN-inducible
genes examined, however, induction of ICE mRNA was com-
pletely defective in Daudires cells, suggesting that the loss of
ICE induction plays a role in the IFN resistance of this cell
line. This prompted us to analyze the mechanisms of tran-
scriptional activation of the ICE gene by IFN.
3.2. IFN-K-induced binding of IRF-1 and IRF-2 in the Inr
element of human ICE promoter
Transcriptional regulation of the ICE gene is not fully
understood. Human ICE promoter has a CAAT box at the
position of 52 bp relative to the transcription start site, but
lacks a classical TATA motif [7]. Instead of the TATA box, it
possesses the sequence TTTCAGTTTC encompassing the
transcription start site (Fig. 1). This sequence is highly con-
served between human and mouse, and matches the consensus
of the initiator (Inr) element, PyPyCANPyPyPyPy [10], sug-
gesting that transcription of the TATA-less ICE gene is pri-
marily driven by the Inr element. Furthermore, upon inspec-
tion of this element, we have found that its core sequence
(TTCAGTTT) conforms to the consensus of IRF-binding el-
ement (IRF-E), TTCNNTTT [11]. This led us to test whether
Fig. 1. Structure of the human ICE promoter and reporter plasmids used in this study. A 5P-untranslated region of the human ICE promoter
(nucleotide positions 3182 to +42) was subcloned into a promoterless CAT vector (pCAT-5P-ICE-WT). This segment includes a CAAT box
(352 to 349), the Inr/IRF-binding element (310 to +1), and the transcription initiation site (+1). A mutant vector pCAT-5P-ICE-MT was gen-
erated by introducing a non-binding mutation into the IRF-E at the positions indicated by asterisks. The sequence between 316 and +10 of
each construct was used as probes for gel-shift assays.
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IFN-induced activation of the ICE gene is regulated by the
binding of IRFs to its Inr element.
We ¢rst examined whether IRF proteins actually bound to
the Inr/IRF-E of ICE promoter in an IFN-dependent manner.
As shown in Fig. 3, three speci¢c complexes, designated as A,
B and BP, were detectable by gel-retardation assays with oli-
gonucleotide probe corresponding to the Inr/IRF-E of ICE
promoter; other bands (indicated by asterisks) were consid-
ered to be non-speci¢c, because they were not detected in a
reproducible manner. Then, we identi¢ed the nature of each
complex by antibody perturbation experiments. Anti-IRF-1
antibody eliminated band A and BP, which resulted in the
appearance of shifted bands (dashed arrows). Anti-IRF-2 re-
moved a signi¢cant amount of the complex B to the position
indicated by a solid arrow (Fig. 3b). In contrast, the com-
plexes were una¡ected by antibodies against STAT proteins
(STAT1 and STAT2) and other IRF family proteins (ICSBP
and ISGF3Q) (data not shown).
To negate the possibility that other factors bind to this site,
we carried out the same experiments with the mutated probe.
The mutation was designed to retain the consensus of the Inr
element but lose the ability to bind IRF proteins (Fig. 1).
Therefore, this probe could render other Inr-binding proteins,
such as TAFII150 [12], YY1 [13] and USF [14], visible if they
bound to the ICE promoter in addition to IRFs. No DNA-
binding complex was observed in IFN-treated Daudisen ex-
tracts when the mutant probe was used (Fig. 3c), indicating
that IRFs are the sole molecules which bind to the Inr element
of the ICE promoter along with IFN-induced ICE mRNA
expression. However, it is still possible that other members
of the IRF family are the components of the complex, since
B and BP were not completely eliminated even by the combi-
nation of anti-IRF-1 and anti-IRF-2 (data not shown).
We then examined the e¡ects of IFN on IRF binding to the
ICE promoter. As shown in Fig. 3a, a small amount of IRF-1
(BP) was observed in both cell lines before IFN treatment,
suggesting a role for IRF-1 in basal-level transcription of
Fig. 2. Expression of the molecules involved in signal transduction
and function of IFN in Daudisen and Daudires cells. The cells were
cultured in the absence or presence of 250 IU/ml of IFN-K for up
to 48 h. Total cellular RNA and whole cell lysates were prepared at
the indicated time points, and subjected to semiquantitative RT-
PCR (a) and immunoblotting (b). Data shown are representatives of
three independent experiments.
Fig. 3. Binding of IRF proteins to the Inr element of ICE promoter. a: Nuclear extracts were prepared from IFN-treated cells at the indicated
time points and incubated with (32P)-labeled oligonucleotides corresponding to the Inr element of the ICE promoter. Speci¢c complexes are in-
dicated by A, B and BP and non-speci¢c bands are indicated by asterisks. b: Nuclear extracts from Daudisen cells after 24 h treatment with
IFN-K were incubated with WT probe in the absence (3) or the presence of speci¢c antibodies against IRF-1 and IRF-2, or a 100-fold molar
excess of the unlabeled oligonucleotides (cold oligo), and subjected to native acrylamide gel electrophoresis. c: Gel-shift assays were performed
with either WT probe or MT probe.
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ICE. IFN-K increased IRF-1 binding (A and BP) in Daudisen
cells after 2 h along with striking induction of IRF-2 (B)
which showed a peak of intensity at 24 h. In contrast, IRF-
1 binding was not enhanced and much less IRF-2 was induced
in IFN-treated Daudires cells, suggesting that the defective
binding of IRFs is responsible for the lack of ICE induction
in this cell line.
3.3. IFN activated the ICE promoter through the binding of
IRFs to its Inr element
Next, we tried to clarify the functional signi¢cance of the
binding of IRFs to the ICE promoter. For this purpose, we
¢rst examined whether IFN-K could activate transcription
from the ICE promoter. The 222 bp fragment of the ICE
promoter, which was de¢ned as a minimal promoter in our
pilot experiments (data not shown), was subcloned into a
promoterless CAT vector (pCAT-5P-ICE-WT, see Fig. 1 for
the structure) and used as a reporter plasmid. We also gen-
erated a mutated vector pCAT-5P-ICE-MT by introducing a
non-binding mutation into the IRF-E. These plasmids, with
empty pCAT-basic vector as a negative control, were transi-
ently transfected into Daudisen cells, and intracellular CAT
activity was measured after 24 h of culture with or without
IFN-K. As anticipated, IFN-K was able to increase the activity
of wild-type promoter 5.5-fold relative to the untreated cells
(Fig. 4a). IFN-K failed to activate the mutated promoter, in-
dicating that IFN-induced transcription of the ICE gene is
totally dependent on the binding of IRFs to its Inr element.
In addition, the basal activity of the ICE promoter is also
likely to be regulated by the same mechanism, since the
CAT activity of pCAT-5P-ICE-MT was signi¢cantly lower
than that of pCAT-5P-ICE-WT in untreated cells.
We then carried out the same experiments with IFN-resist-
ant Daudires cells. As shown in Fig. 4b, IFN-induced activa-
tion of the wild-type promoter was signi¢cantly reduced in
Daudires cells (P6 0.01 vs. Daudisen cells by Student’s t-
test). The mutated promoter was also unresponsive to IFN-
K in Daudires cells. These results clearly show that binding of
IRFs is essential for basal and IFN-induced transcriptional
activation of the ICE gene, and also suggest that the defect
in this system underlies IFN resistance in Daudires cell line.
3.4. Forced IRF-1 expression resulted in ICE promoter
activation in the Daudires cell line
Finally, we investigated whether ectopic IRF expression
could activate the ICE promoter in the Daudires cell line. As
shown in Fig. 5, ICE promoter activity was increased in
Daudires cells to the level of that in Daudisen cells when
IRF-1 was overexpressed. Under this condition, IFN was
able to slightly enhance the promoter activity in both Daudisen
and Daudires cells. In contrast, forced expression of IRF-2
resulted in remarkable suppression of ICE promoter activity
(data not shown).
4. Discussion
The mechanisms of IFN resistance have been investigated
by many researchers using IFN-resistant cell lines. Loss of
receptor expression and function was shown to be responsible
for IFN resistance in H82 (human lung cancer cell line) [15],
Capan 2 (human pancreatic carcinoma cell line) [16], and
IFN-resistant variants of Daudi and HeLa [17]. In addition,
defects in the expression and activation of STAT1 and STAT2
were reported to be a major cause of IFN resistance in some
cell lines [17^19]. To further investigate the mechanisms of
IFN resistance, we have established a novel IFN-resistant
cell line Daudires from IFN-sensitive Daudi cells (Daudisen)
by long-term exposure to IFN-K. It was shown that signal
transduction from IFN receptors to STAT was not severely
impaired in Daudires cells unlike in the other cell lines de-
Fig. 4. IFN-K enhanced ICE promoter activity in an IRF-dependent
manner. Reporter plasmids, pCAT-5P-ICE-WT (WT) and pCAT-5P-
ICE-MT (MT), were transfected into Daudisen (a) and Daudires (b)
cells. Empty pCAT-basic vector was used as a negative control (ba-
sic). The cells were split equally into two fractions, and cultured in
the absence (open bars) or presence (shaded bars) of 250 IU/ml of
IFN-K. CAT activity was measured after 24 h. Relative CAT activ-
ity was determined with the value obtained from untreated Daudisen
cells transfected with pCAT-5P-ICE-WT set at 1.0 (shown by an as-
terisk). The mean þ S.D. (bar) of ¢ve independent experiments is
shown.
Fig. 5. E¡ect of IRF-1 overexpression on ICE promoter activity.
IRF-1 expression plasmid was transfected into Daudisen and
Daudires cells with pCAT-5P-ICE-WT and pSV-L-gal vectors. Empty
pCR3.1 vector was used for mock transfection. The cells were split
equally into two fractions and IFN-K was added to one (shaded
bars). Relative CAT activity was determined as the fold increase
against the value obtained from untreated mock-transfected
Daudisen cells. All values were normalized to L-galactosidase activ-
ity. The mean þ S.D. (bar) of ¢ve independent experiments is
shown.
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scribed above. Among the IFN-inducible genes examined,
only for the ICE gene was mRNA induction defective in
Daudires cells.
Then, we investigated the mechanisms of ICE induction by
IFN-K. Transcriptional regulation of the ICE gene is not fully
understood, although genomic cloning has already been done
in both human and mouse [7]. Human ICE promoter lacks a
classical TATA motif and, instead, has an Inr element, which
may be responsible for transcription of the ICE gene. In this
study, we found that binding of IRFs to this element coin-
cided with ICE mRNA induction by IFN-K. Mutation at the
Inr/IRF-E, which prevents IRF binding but retains Inr func-
tion, completely abrogated IFN-induced activation of the ICE
promoter. This indicates that IFN-induced transcriptional ac-
tivation of the ICE gene is completely dependent on IRF
binding to its Inr element. Our ¢nding explains why ICE
mRNA is defective in mitogen-stimulated T-lymphocytes
from IRF-1 knock out mice [20].
In TATA-less promoters, the Inr element is critical in posi-
tioning RNA polymerase II, and is believed to initiate tran-
scription according to two di¡erent models [10]. In one model,
RNA polymerase II recognizes the Inr element directly and
forms a transcription competent complex with TBP, TFIIB,
and TFIIF. In the alternative model, Inr element-binding pro-
teins interact with components of the general transcriptional
machinery to assemble a transcription competent complex.
Two Inr-binding proteins, cap-site-binding factor [21] and
TFII-I [22], start transcription from the adenovirus major
late promoter according to the latter model. In this study,
we have found that IRF-1 acts as an Inr-binding protein
and plays a crucial role in IFN-induced transcription of the
ICE gene. To our knowledge, this is the ¢rst report to dem-
onstrate IRF-1 acts as an Inr-binding protein for a native
promoter. Recently, Wang et al. [23] reported that recombi-
nant IRF-1 physically associated with TFIIB and coopera-
tively regulated IFN-responsive promoter activity. This ¢nd-
ing supports our notion very well.
Binding of IRFs to the ICE promoter was markedly dimin-
ished in IFN-resistant Daudires cells, and ectopic IRF-1 ex-
pression was able to activate the ICE promoter to the level in
Daudisen cells. How is the loss of IRF binding implicated in
IFN resistance? Although the defect in ICE expression may
a¡ect IFN resistance in some manner, the antiproliferative
e¡ect of IFNs is not solely due to the induction of apoptosis,
especially in Daudi cells in which apoptosis is hardly induced
(Iwase, S. et al., unpublished data). Therefore, it is possible
that, in addition to ICE, IRFs regulate the transcription of
other genes which play crucial roles in the antiproliferative
action of IFNs, and their defect is primarily responsible for
IFN resistance of IRF-de¢cient cells. An earlier study of Ozes
and Taylor [24] provides a good example of such a scenario.
They have described that indoleamine 2,3-dioxygenese is es-
sential for growth inhibition of human cervical carcinoma cell
line ME180 by IFN-Q, and its induction is completely depend-
ent on IRF-1. IFN-Q-mediated induction of IRF-1 and, sub-
sequently, indoleamine 2,3-dioxygenese is defective in the
IFN-resistant variant of ME180. We are now trying to iden-
tify other IRF-dependent genes implicated in IFN resistance
of Daudires cells. Taken together, these results suggest that
multiple interrelated mechanisms are involved in IFN resist-
ance, and a comprehensive approach is required to elucidate
the molecular basis of the resistance in each case.
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